Search results for: 'tech of use'

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...

Home care digitalization continues to gain strong momentum, driven by the rapid growth of the elderly population, increasing prevalence of multi-morbidity, persistent workforce shortages, and rising cost and efficiency pressures on payers and public health systems. Population aging is not only increasing the volume of home care but also its complex...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...

This study examines how healthcare organizations are advancing their cloud strategies amid rising demand for AI, increased financial pressures, and growing operational complexity. Findings show that the cloud has become the core foundation of digital transformation, with adoption shifting from basic migration toward modernization, automation, and A...

The report describes how predictive biomarkers are changing the global landscape of neuroregeneration and transitioning from the concept of control of brain injury to an active repair of the brain. This report describes how brain injuries from scans were being replaced by blood tests being developed to measure the burden of Alzheimer's disease, mea...

The global healthcare cloud market is expanding as healthcare organizations move beyond early cloud adoption and begin to use cloud environments as a foundation for managing data, enabling interoperability, and supporting more integrated clinical and operational workflows. As adoption matures, cloud is increasingly being positioned not just as infr...

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...